Buying into a stock pre commercialisation, where revenue is less...

Buying into a stock pre commercialisation, where revenue is less than expenses such as R&D and the like, is always going to be a slow increase in market cap relative to the share price. Where contributed funds (cap raises) are used for such expenses.The obvious other option is debt, which considering the large increase in interest rates over the last 18 months, has its on costs.

However, what are your options as a retail investor if you believe in the tech. Do you wait until commericialisation, when every Tom, Dick and Harry know about its success and have pushed the price beyond good value. Or do you continually buy in over time, averaging when you see price drops.

Personally, I would rather be earlier than later - and at current values - it's a steal.

The fact that the price has remained at around $20 (obviously forgetting about last year's jump to $30) has showed that no-one is really selling. As it is still very thinly traded.

Gussy out